Total Payments
$596,813
2024 Payments
$107,191
Companies
16
Transactions
896
Payment Breakdown by Category
Other$467,464 (78.3%)
Consulting$67,033 (11.2%)
Travel$46,885 (7.9%)
Food & Beverage$14,947 (2.5%)
Education$486.09 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $467,464 | 205 | 78.3% |
| Consulting Fee | $67,033 | 32 | 11.2% |
| Travel and Lodging | $46,885 | 279 | 7.9% |
| Food and Beverage | $14,947 | 362 | 2.5% |
| Education | $486.09 | 18 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $429,161 | 605 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $84,279 | 82 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $46,646 | 95 | $0 (2024) |
| Axsome Therapeutics, Inc. | $26,266 | 26 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $6,742 | 15 | $0 (2017) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $2,485 | 11 | $0 (2022) |
| ITI, Inc. | $359.16 | 15 | $0 (2023) |
| AbbVie Inc. | $252.95 | 19 | $0 (2023) |
| Allergan, Inc. | $158.73 | 8 | $0 (2020) |
| Indivior Inc. | $125.42 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107,191 | 100 | Neurocrine Biosciences, Inc. ($39,209) |
| 2023 | $130,031 | 130 | Otsuka America Pharmaceutical, Inc. ($44,988) |
| 2022 | $60,517 | 102 | Otsuka America Pharmaceutical, Inc. ($59,829) |
| 2021 | $45,880 | 80 | Otsuka America Pharmaceutical, Inc. ($43,232) |
| 2020 | $47,604 | 98 | Otsuka America Pharmaceutical, Inc. ($47,442) |
| 2019 | $94,230 | 195 | Otsuka America Pharmaceutical, Inc. ($93,660) |
| 2018 | $69,265 | 107 | Otsuka America Pharmaceutical, Inc. ($69,182) |
| 2017 | $42,096 | 84 | Otsuka America Pharmaceutical, Inc. ($35,235) |
All Payment Transactions
896 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neuroscience | ||||||
| 12/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neuroscience | ||||||
| 12/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neuroscience | ||||||
| 12/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Neuropsychiatry | ||||||
| 11/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,960.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,724.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $122.73 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $144.51 | General |
| Category: Neuroscience | ||||||
| 10/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,763.00 | General |
| Category: Neuropsychiatry | ||||||
| 10/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,960.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,724.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $227.46 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $877.50 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $965.25 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neuroscience | ||||||
| 07/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Neuroscience | ||||||
About Dr. David Smith, M.D
Dr. David Smith, M.D is a Psychiatry healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114902178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Smith, M.D has received a total of $596,813 in payments from pharmaceutical and medical device companies, with $107,191 received in 2024. These payments were reported across 896 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($467,464).
Ad
Practice Information
- Specialty Psychiatry
- Location Sacramento, CA
- Active Since 12/13/2005
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1114902178
Products in Payments
- REXULTI (Drug) $221,517
- ABILIFY MAINTENA (Drug) $203,982
- INGREZZA (Drug) $84,279
- SPRAVATO (Drug) $46,457
- Auvelity (Drug) $26,266
- Trintellix (Drug) $6,717
- ABILIFY ASIMTUFII (Drug) $3,847
- CAPLYTA (Drug) $461.65
- VRAYLAR (Drug) $390.08
- INVEGA SUSTENNA (Drug) $171.46
- PERSERIS (Drug) $125.42
- Vivitrol 380 mg (Drug) $64.53
- Dyanavel XR (Drug) $58.69
- ARISTADA (Drug) $43.58
- ABILIFY MYCITE (Drug) $31.38
- GRALISE (Drug) $26.37
- LATUDA (Drug) $19.88
- INVEGA TRINZA (Drug) $16.69
- UBRELVY (Drug) $13.95
- VIIBRYD (Drug) $7.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Sacramento
Jacob Adams, Md, MD
Psychiatry — Payments: $300,724
Psychiatry $300,724
Robert Mccarron, D.o, D.O
Psychiatry — Payments: $60,946
Psychiatry $60,946
Mandeep Behniwal, M.d, M.D
Psychiatry — Payments: $31,382
Psychiatry $31,382
Janak Mehtani, M.d, M.D
Psychiatry — Payments: $29,471
Psychiatry $29,471
Dr. Wei-Hsun Liao, M.d. Ph.d, M.D. PH.D
Psychiatry — Payments: $15,066
Psychiatry $15,066
Donald Hilty, M.d., M.b.a, M.D., M.B.A
Psychiatry — Payments: $10,209
Psychiatry $10,209